GlucoTrack, Inc. (GCTK) Stock

Healthcare · Medical Devices · Member of Other US Stocks

GlucoTrack, Inc. (GCTK) closed at USD 0.89 on 2026-10-14, a change of -99.2 % over the past year, with a market capitalization of USD 846,888.

GlucoTrack, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

GlucoTrack, Inc. key figures

Previous close

USD 0.89 (2026-10-14)

1-year change

-99.2 %

Market cap

USD 846,888

Enterprise value

USD 1.42M

P/E ratio (trailing)

-0.01

P/E ratio (forward)

n/a

EPS (trailing)

-90.99

EPS (forward)

n/a

PEG ratio

n/a

Price to book

-0.20

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.03

Employees

15

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About GlucoTrack, Inc.

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for GlucoTrack, Inc. and compare it with other stocks.